Crossroads in Cultural Studies Conference 14-17th December 2016 Program Index
Crossroads-2016-final-draft-program-30-Nov
Crossroads-2016-final-draft-program-30-Nov
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
consumption, and start new cultural phenomena. This paper provides analysis and research on typical cases, and its<br />
f<strong>in</strong>d<strong>in</strong>gs <strong>in</strong>dicate a new representation of contemporary Ch<strong>in</strong>ese Media Culture. On the one hand, We media develop<br />
the enterta<strong>in</strong><strong>in</strong>g media culture. On the other hand, We media provide new cultural space <strong>in</strong> which people can<br />
construct cultural identity.<br />
10K<br />
Cultures of Drug Use (Chair, Adrian Farrugia)<br />
Roberta Pala<br />
Vacc<strong>in</strong>e Refusal and Governmental Responses<br />
The prevalent understand<strong>in</strong>g of vacc<strong>in</strong>e refusal ascribes responsibility to vacc<strong>in</strong>e objectors. The Australian<br />
government’s “no jab no pay” policy penalises, among the unvacc<strong>in</strong>ated, those who require family benefits<br />
and locates conscientious objectors as the ma<strong>in</strong> source of vacc<strong>in</strong>e refusal, ignor<strong>in</strong>g other circumstances for<br />
non-vacc<strong>in</strong>ation. An analysis of how this “evidence-based policy” problematises non-vacc<strong>in</strong>ation shows a<br />
privileg<strong>in</strong>g of vacc<strong>in</strong>e beliefs over the practical circumstances of non-vacc<strong>in</strong>ation. I highlight a crucial<br />
discrepancy: while on one side the policy subord<strong>in</strong>ates <strong>in</strong>dividual reluctance to the prerogatives of public<br />
health, on the other hand it <strong>in</strong>dividualises the vacc<strong>in</strong>e decisions of non-compliants as deviant. In this way it<br />
demonises non-compliance <strong>in</strong>stead of engag<strong>in</strong>g with the conditions that <strong>in</strong>form it, <strong>in</strong> a pre-emptive<br />
manoeuvre that works aga<strong>in</strong>st creat<strong>in</strong>g engaged communities. The antagonistic state of the vacc<strong>in</strong>e debate<br />
precludes more practical and ethical engagements with difference.<br />
Janelle Applequist<br />
Fetishism<br />
Disease Brand<strong>in</strong>g <strong>in</strong> Western Medic<strong>in</strong>e: Advertis<strong>in</strong>g Discourse that Promotes Pharmaceutical<br />
Prescription drug advertisements have become a popular aspect of consumer culture <strong>in</strong> the United States.<br />
To provide a more <strong>in</strong>-depth look at the ways <strong>in</strong> which a prescription drug is advertised and produced, this<br />
manuscript uses a case study approach, utiliz<strong>in</strong>g multivariate data, a political economy approach, critical<br />
advertis<strong>in</strong>g studies, and textual analysis to deconstruct one especially noteworthy campaign, the<br />
prescription-only contraceptive YAZ. “Disease monger<strong>in</strong>g” and “disease brand<strong>in</strong>g” have become often-seen<br />
components <strong>in</strong> Western medic<strong>in</strong>e. A textual analysis of a YAZ advertisement that aired <strong>in</strong> 2010 will be<br />
conducted to analyze the consumerist discourses present <strong>in</strong> Western health care. After this advertisement<br />
aired <strong>in</strong> 2010, various health effects were found to be associated with the drug, <strong>in</strong>clud<strong>in</strong>g heart attack,<br />
stroke, and blood clott<strong>in</strong>g. As Bayer cont<strong>in</strong>ued to fight the negative publicity surround<strong>in</strong>g the health<br />
problems associated with tak<strong>in</strong>g YAZ, <strong>in</strong> 2011, they <strong>in</strong>troduced a new drug, Beyaz. Beyaz is chemically<br />
identical to YAZ, but has added Folic Acid (Vitam<strong>in</strong> B-9), mak<strong>in</strong>g it legal to market the drug as a new formula.<br />
Yet, Beyaz still conta<strong>in</strong>s the controversial synthetic progest<strong>in</strong> drospirenone (Emison, 2011). To date, if you<br />
visit the website for YAZ, both YAZ and Beyaz are marketed together. This means that Bayer arguably rolled<br />
out a nearly identical birth control pill, simply giv<strong>in</strong>g it a new name for consumers to associate with more<br />
positively, but carry<strong>in</strong>g with it all the same side effects found previously with YAZ (Emison, 2011).<br />
Additionally, the ad presents Premenstrual Dysphoric Disorder (PMDD) as a serious ailment need<strong>in</strong>g to be<br />
addressed. In this sense, it can be argued that PMDD, already classified as a form of disease monger<strong>in</strong>g or<br />
disease brand<strong>in</strong>g, is cont<strong>in</strong>u<strong>in</strong>g to be portrayed to consumers as a more serious, more severe condition that<br />
requires <strong>in</strong>dividual <strong>in</strong>tervention. The pharmaceutical ideology that puts profit above patient understand<strong>in</strong>g<br />
further perpetuates a system of self-diagnosis, as can be seen via the example of PMDD <strong>in</strong> the YAZ<br />
advertisement, where a message is distributed that celebrates the commodity while seamlessly appear<strong>in</strong>g to<br />
put decisions about health <strong>in</strong>to the hands of consumers. YAZ serves as an example of pharmaceutical<br />
fetishism, seen mostly through its brand<strong>in</strong>g associated with fem<strong>in</strong>ist empowerment, which celebrates the<br />
252